PREVALENCE OF CYTOPENIAS IN PATIENTS LIVING WITH THE HUMAN IMMUNODEFICIENCY VIRUS. AN OBSERVATIONAL COHORT STUDY.

EHA Library, Theofilo Miguel de Luca, 134790

IMMUNOGLOBULIN SUPPLEMENTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA TREATMENT IN A SINGLE PEDIATRIC INSTITUTION: COMPARISON BETWEEN TWO CONSECUTIVE AIEOP CLINICAL TRIALS.

EHA Library, Rosanna Parasole, 134791

CANDIDAEMIA SPECTRUM: RESULTS OF A THREE-YEAR ANALYSIS AT THE PEDIATRIC HAEMATOLOGY ONCOLOGY CENTRE, RUSSIA

EHA Library, Valentina Pirumova, 134792

RISK FACTORS FOR INFECTION AND HIGH MORTALITY RATE AMONG PATIENTS WITH KPC PRODUCING KLEBSIELLA PNEUMONIAE BACTERAEMIAS IN A HAEMATOLOGY UNIT

EHA Library, ATHANASIOS Galanopoulos, 134793

PLASMA POSACONAZOLE CONCENTRATION DURING CONCOMITANT TREATMENT WITH PROTON PUMP INHIBITHOR OMEPRAZOLE IN ADOLESCENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT.

EHA Library, Michela Ribersani, 134794

A NOVEL MARKER FOR DIFFERENTIAL DIAGNOSIS BETWEEN HEPATITIS B AND HEPATITIS C USING ROUTINE COMPLETE BLOOD COUNT AND CELL POPULATION DATA

EHA Library, Jimin Kahng, 134795

PREVENTION AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES - RESULTS FROM A SINGLE HEMATOLOGICAL CENTRE

EHA Library, Gabriella Serke, 134796

EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS OF BLOODSTREAM INFECTIONS IN HEMATOLOGICAL CANCER PATIENTS

EHA Library, Vitalii Chebotkevich, 134797

SIMULTANEOUSLY MONITORING OF SERUM AND URINE CYTOMEGALOVIRUS DNA IN PATIENTS UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Ying Lu, 134798

MORTALITY PREDICTORS IN PATIENTS WITH BLOOD MALIGNANCIES IN INTENSIVE CARE UNIT AFTER CHEMOTHERAPY.

EHA Library, Bulat Bakirov, 134799

INVASIVE FUNGAL INFECTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE IN TURKEY

EHA Library, Turkan Patıroglu, 134800

EPIDEMIOLOGY AND PROGNOSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES ADMITTED TO INTENSIVE CARE

EHA Library, Regaieg Haifa, 134801

USEFUL CLINICAL FEATURES AND HEMATOLOGICAL PARAMETER FOR THE DIAGNOSIS OF DENGUE INFECTION IN ACUTE FEBRILE ILLNESS PATIENTS

EHA Library, Adisak Tantiworawit, 134802

DIFFERENT WHO SUBTYPES OF CHROMOSOMALLY NORMAL MDS SHARE COMMON AMPLIFIED AREAS ON ACGH/SNPA.

EHA Library, Paolo Bernasconi, 134803

THE ASXL1 GENE ALTERATIONS IN BONE MARROW CELLS OF PATIENTS WITH DELETION 20Q AND MYELOID DISORDERS

EHA Library, Jana Brezinova, 134804

ASSOCIATION BETWEEN POLYMORPHISM OF FOLATE AND METHIONINE METABOLISM RELATED GENES AND ABERRANT DNA METHYLATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Zhanna Sidorova, 134805

DEPLETION OF PROINFLAMMATORY MONOCYTES AND INCREASED LEVELS OF CD56 EXPRESSION ON CLASSICAL MONOCYTES IN THE PERIPHERAL FROM PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Renata Cabral, 134806

PRIMARY RESISTANCE TO AZACYTIDINE IN MDS: PRELIMINARY DATA ON THE POTENTIAL ROLE OF HIF-1A EXPRESSION

EHA Library, Vassiliki Pappa, 134807

PU.1 EXPRESSION CORRELATES WITH PATIENT DISEASE STATUS IN THE MYELODYSPLASTIC SYNDROMES, A NEW PROGNOSTIC MARKER?

EHA Library, Ciro Rinaldi, 134808

MLPA

EHA Library, Dennisse Sharon Toral Ibarra, 134809

CHARACTERIZATION OF THE ERYTHROPOIETIC RESPONSE OF THE DYSPLASTIC MARROW

EHA Library, Marta Pereira, 134810

USEFULNESS OF MUTATIONAL ANALYSIS FOR DIAGNOSIS OF IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND MYELODYSPLASTIC SYNDROME

EHA Library, Dong Soon Lee, 134811

THE USAGE OF NEUT-X AND NEUT-Y PARAMETRES IN A ROUTINE HEMATOLOGY LABORATORY AS DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES (MDS )

EHA Library, Panagiota Tsiatsiou, 134812

LOW LEVELS OF CD10, CD11B, CD13, AND CD16 EXPRESSION IN THE PERIPHERAL BLOOD NEUTROPHILS FROM PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Renata Cabral, 134813

MULTIDISCIPLINARY EVALUATION AT BASELINE AND DURING TREATMENT IMPROVES THE RATE OF COMPLIANCE AND EFFICACY OF DEFERASIROX IN ELDERLY MYELODYSPLASTIC PATIENTS.

EHA Library, Lisette Del Corso, 134814

PEPTIDE VACCINATION AGAINST CANCER TESTIS ANTIGENS IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA: AN ONGOING PHASE I STUDY

EHA Library, Staffan Holmberg, 134815

PROGNOSTIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA FROM SOUTH AMERICA

EHA Library, Jacqueline Gonzalez, 134816

SERUM ERYTHROPOIETIN (SEPO) TESTING, LEVELS, AND SUBSEQUENT TREATMENT PATTERNS FOR TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Aaron T. Gerds, 134817

IS A 1ST LINE ERYTHROPOIETIN APPROACH IN MYELODYSPLASTIC PATIENTS WITH DEL 5Q- USEFUL?

EHA Library, Paola Volpicelli, 134818

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) IN CLINICAL PRACTICE: FREQUENCY AND INDICATIONS

EHA Library, Shannon Wong, 134819

COMPASIVE USE OF 5-AZACITIDINE IN PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES.

EHA Library, Dunia De Miguel Llorente, 134820

A REAPPRAISAL OF THE AZA TREATMENT OUTCOME: ASSESSING THE VALUE OF DISEASE STABILISATION AND EFFECT OF TREATMENT SCHEDULE MODIFICATION

EHA Library, Elena Maria Casartelli, 134821

DIAGNOSTIC VALUE OF PERIODIC ACID-SCHIFF POSITIVITY OF BONE MARROW ERYTHROBLASTS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Rosangela Invernizzi, 134822

NFE2L2,KEAP1AND NQO1GENE EXPRESSION IN MYELODYSPLASTIC SYNDROME AND MONOCLONAL GAMMOPATHIES? CLINICAL IMPLICATIONS

EHA Library, Ana Bela Sarmento-Ribeiro, 134823

BIOSIMILAR ERYTHROPOIETIN ALFA FOR THE THERAPY OF ANEMIA IN ?LOWER RISK? MYELODYSPLASTIC SYNDROMES. INTERIM RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY OF THE ?RETE EMATOLOGICA LOMBARDA? (EPOREL)

EHA Library, Anna Maria Pelizzari, 134824

PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES AND THEIR INFLUENCE ON OVERALL SURVIVAL

EHA Library, Tatjana Sotirova, 134825

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF MYELODYSPLASTIC SYNDROMES (MDS) IN ADULTS ACCORDING TO THE DATA OF MUNICIPAL HEMATOLOGY DEPARTMENTS IN MOSCOW, RUSSIA

EHA Library, Sergey Semochkin, 134826

HIPERFERRITINEMIA IN MYELODISPLASTIC SYNDROME (MSD) PATIENTS.CORELATION WITH EVOLUTION AND SURVIVAL

EHA Library, Hortensia Ionita, 134827

EFFICACY AND SAFETY OF XIAOAIPING TABLETS IN THE TREATMENT OF ELDERLY PATIENTS WITH INTERMEDIATE-RISK/HIGH-RISK MYELODYSPLASTIC SYNDROME: A PILOT TRIAL

EHA Library, Xuemei Sun, 134828

MYELOTOXICITY OF PEPTIDE RECEPTOR RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS: A DECADE OF EXPERIENCE

EHA Library, Murali Kesavan, 134829

ASSESSMENT OF B AND T LYMPHOCYTES FUNCTION IN PATIENTS WITHMYELODYSPLASTIC SYNDROMES

EHA Library, Mohamed Moussa, 134830

DOMICILIARY AZACITIDINE: A NEW EXPERIENCE IN OUR CENTER

EHA Library, Inés Herráez Balanzat, 134831

A RETROSPECTIVE REVIEW OF AZACITIDINE THERAPY IN AN IRISH UNIVERSITY HOSPITAL SETTING

EHA Library, James Nolan, 134832

CLINICAL CHARACTERISTICS, OUTCOME AND PROGNOSTIC FACTORS OF SURVIVAL OF MULTIPLE MYELOMA PATIENTS ACHIEVING AT LEAST VERY GOOD PARTIAL RESPONSE AFTER FIRST LINE TREATMENT IN THE ERA OF NOVEL AGENTS

EHA Library, Evlambia Giannopoulou, 134833

IDENTIFICATION OF PROGNOSTIC RELEVANT GENETIC ABNORMALITIES IN MULTIPLE MYELOMA USING MICROARRAY-BASED GENOMIC PROFILING IN ROUTINE DIAGNOSTICS

EHA Library, Pino Poddighe, 134835

CYR61/CCN1 STIMULATED THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS IN MYELOMA BONE DISEASE IN VITRO

EHA Library, Rong Fu, 134836

STABLE IN VITRO BORTEZOMIB RESISTANCE OF MYELOMA CELLS IS CHARACTERIZED BY CHROMOSOME 1Q21 COPY NUMBER GAIN

EHA Library, Xenofon Papanikolaou, 134837

ROLE OF EPO IN THE ANGIOGENIC ACTIVITY OF BONE MARROW ENDOTHELIAL CELLS OF MGUS AND MULTIPLE MYELOMA PATIENTS

EHA Library, Domenico Ribatti, 134838

POLYMORPHISM OF IL-10 RECEPTOR ? AFFECTS THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE AND/OR BORTEZOMIB

EHA Library, Tetsuhiro Kasamatsu, 134839

DIETARY HABITS ACROSS THE LIFESPAN AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A POPULATION-BASED SCREENING STUDY

EHA Library, Marianna Thordardottir, 134840

HEAVY-LIGHT CHAIN IMMUNOASSAYS FOR DIAGNOSIS AND MONITORING IGA MULTIPLE MYELOMA: SAVING PITFALLS ON PROTEIN QUANTIFICATION

EHA Library, Marcio Andrade-Campos, 134841

IL-1R AND IL-1RA IN THE DEVELOPMENT OF MULTIPLE MYELOMA

EHA Library, Anastasia Pavlova, 134842

ZOLEDRONIC ACID INHIBITS CELL GROWTH OF MULTIPLE MYELOMA CELLS AND SHOWS SYNERGISTIC ANTIMYELOMA EFFECTS WITH BORTEZOMIB VIA DOWNREGULATION OF PIM-2 THROUGH NF-KB PATHWAY

EHA Library, Rong Fu, 134843

VALIDATION OF REVISED INTERNATIONAL STAGING SYSTEM (R-ISS) IN THE ERA OF NOVEL AGENTS: REAL-WORLD DATA ON 481 MYELOMA PATIENTS FROM A GREEK MYELOMA CENTER

EHA Library, Evlambia Giannopoulou, 134844

THE EFFECT OF HYPOXIA ON NOTCH PATHWAY IN MULTIPLE MYELOMA NICHE

EHA Library, Silvia Garavelli, 134845

A NOVEL TOOL TO MONITOR ANGIOGENESIS IN BONE MARROW SMEARS: DETECTION AND QUANTIFICATION OF ENDOTHELIAL PROGENITOR CELLS BY MULTIPLE-LABELING IMMUNOFLUORESCENCE ANALYSIS

EHA Library, Maria Tenreiro, 134846

THE EFFECT OF MIR-146A OVEREXPRESSION ON THE PROLIFERATION AND APOPTOSIS OF MULTIPLE MYELOMA CELL LINE

EHA Library, Shima Kazemzadeh, 134847

MAST CELLS INDUCE MYELOMA PLASMA CELLS? PROLIFERATION

EHA Library, Georgios Tsirakis, 134848

EARLY DETECTION OF PLASMA CELL DYSCRASIA IN SERUM PROTEIN ELECTROPHORESIS

EHA Library, Manuela rebordao, 134849

SERUM LEVELS OF E-SELECTIN AND VCAM-1 IN ACTIVE MYELOMA

EHA Library, Georgios Tsirakis, 134850

RISK FACTORS ASSOCIATED WITH EARLY MORTALITY IN PATIENTS WITH MULTIPLE MYELOMA IN THE NOVEL-AGENTS ERA

EHA Library, Sung-Hoon Jung, 134851

EXPECTANCY OF LIFE AND INCIDENCE RATE OF NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS. 15 YEARS RETROSPECTIVE ANALYSIS

EHA Library, FERNANDO ESCALANTE BARRIGON, 134852

IMPACT OF TIME SPENT WAITING FOR AUTOLOGOUS TRANSPLANTATION ON THE OUTCOME OF PATIENTS WITH MULTIPLE MYELOMA.

EHA Library, Francesco Ripamonti, 134853

SINGLE CENTRE OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA.

EHA Library, Tom Rider, 134854

OUTPATIENT STEM CELL MOBILIZATION WITH INTERMEDIATE-DOSE CYCLOPHOSPHAMIDE IS A SAFE AND EFFECTIVE PROCEDURE

EHA Library, Alessandra Pompa, 134855

CLINICAL CHARACTERISTICS OF PATIENTS WITH MULTIPLEMYELOMA. PRELIMINARY RESULTS OF A PROSPECTIVEMULTICENTER REGISTRY OF THE COMUNIDAD VALENCIANA(SPAIN).

EHA Library, Javier DE LA RUBIA, 134856

PATIENT REPORTED OUTCOMES (PROS) OF MULTIPLE MYELOMA (MM) PATIENTS FROM THE PANORAMA-1 STUDY WHO HAVE RECEIVED AT LEAST TWO PRIOR REGIMENS INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT.

EHA Library, Paul G Richardson, 134857

RETROSPECTIVE COHORT ANALYSIS EXAMINING THE EFFICACY AND SAFETY OF (V)DTPACE IN NEWLY DIAGNOSED AND RELAPSED/REFRACTORY MYELOMA PATIENTS ? THE UK EXPERIENCE

EHA Library, Priya Sriskandarajah, 134858

THE ROLE OF COMORBIDITY ON EARLY MORTALITY IN MULTIPLE MYELOMA. A SINGLE INSTITUTION POPULATION-BASED STUDY EMPHASIZING THE NEED FOR STANDARDIZATION

EHA Library, Rafael Rios-Tamayo, 134859

CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Masaki Ri, 134860

PROGNOSTIC SIGNIFICANCE OF EXTRAMEDULLARY DISEASE DETECTED BY PET/CT ON OUTCOMES OF AUTOLOGOUS TRANSPLANT IN MULTIPLE MYELOMA PATIENTS

EHA Library, Uday Yanamandra, 134862

ASSOSIATION BETWEEN ENDOTHELIAL AND PLATELET DERIVED MICROPARTICLES AND VENOUS THROMBOSIS IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA (MM) AND NON HODGKIN LYMPHOMA (NHL) - PRELIMINARY REPORT

EHA Library, Lidia Usnarska-Zubkiewicz, 134863

GALECTIN-3 AS A PREDICTOR OF STATIN TREATMENT EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Boris Samura, 134864

CLINICAL SIGNIFICANCE OF OSTEOBLAST PRECURSORS AND OSTEOCLAST PRECURSORS IN EARLIER DIAGNOSIS AND MONITORING OF MYELOMA BONE DISEASE

EHA Library, Rong Fu, 134865

BORTEZOMIB IN COMBINATION WITH HIGH DOSE MELPHALAN AS CONDITIONING REGIMEN IS SAFE AND IMPROVES THE RESPONSE RATES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.

EHA Library, Anna Benedetta Dalla Palma, 134866

OSTEONECROSIS OF THE JAW IN PATIENTS WITH MULTIPLE MYELOMA IN THE ERA OF MORE POTENT BISPHOSPHANATES

EHA Library, Marica Pavkovic, 134867

A PHASE 2 MULTICENTER STUDY OF POMALIDOMIDE IN COMBINATION WITH LOW-DOSE DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: THE MM-011 TRIAL

EHA Library, Shotaro Hagiwara, 134868

IMPACT OF ERYTHROPOIESIS STIMULATING AGENTS ON OVERALL SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Sebastián Ortiz Zuluaga, 134869

FDG-PET/CT IN MULTIPLE MYELOMA A CORRELATION OF SUV AND ISS SCORE

EHA Library, Brian Østergaard, 134870

INFECTIONS IN MULTIPLE MYELOMA: AN UNDERSTIMATE RISK FACTOR OF COMORBIDITY

EHA Library, Gregorio Barilà, 134871

PREVALENCE OF OCULAR DISORDERS IN MULTIPLE MYELOMA

EHA Library, Martina Pennisi, 134872

BENDAMUSTINE-BORTEZOMIB-DESAMETASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA : A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 134873

SECOND MALIGNANCIES AND MULTIPLE MYELOMA. A SINGLE-INSTITUTION EXPERIENCE IN SPAIN

EHA Library, Seila Cerda, 134874

A PHASE 2 TRIAL OF SMALL-DOSE BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (SVRD) AS CONSOLIDATION/MAINTENANCE THERAPY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Tsutomu Sato, 134875

BONE MARROW RETICULIN FIBROSIS AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED IN THE ERA OF NOVEL AGENTS

EHA Library, Celia Suriu, 134876

LEPTOMENINGEAL MYELOMATOSIS ? A RARE COMPLICATION IN MULTIPLE MYELOMA

EHA Library, Martin Bommer, 134877

A PHARMACOKINETICS CLINICAL STUDY OF BORTEZOMIB SUBCUTANEOUS INJECTION VERSUS INTRAVENOUS INJECTION COMBINED WITH CHEMOTHERAPY IN CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA-INTERIM RESULTS

EHA Library, Chengcheng Fu, 134878

CHEMOTHERAPY ADHERENCE IS FAVORABLE PROGNOSTIC FACTOR FOR ELDERLY PATIENTS WITH MULTIPLE MYELOMA WHO TREATED WITH FRONTLINE BORTEZOMIB CONTAINING REGIMEN

EHA Library, Joon Ho MOON, 134879

PROGNOSTIC SIGNIFICANCE OF EXPRESSION OF MULTIDRUG RESISTANCE GENES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BORTEZOMIB-CONTEINING THERAPHY

EHA Library, Yulia Chernykh, 134880

THE STRATUS TRIAL (MM-010): ANALYSIS OF THE ITALIAN SUBGROUP OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE

EHA Library, Michele Cavo, 134881

RISK OF HYPERTENSION (HTN) AND MALIGNANT HYPERTENSION (MHTN) IN PATIENTS TREATED FOR MULTIPLE MYELOMA (MM)

EHA Library, Ajai Chari, 134882

DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE

EHA Library, Marco Capecchi, 134883

TRABECULAR BONE SCORE (TBS) AND DEVELOPMENT OF FRACTURE IN MULTIPLE MYELOMA

EHA Library, Eun Mi Lee, 134884

BORTEZOMIB MAINTENANCE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA-A SINGLE CENTER EXPERIENCE

EHA Library, Ilina Micheva, 134885

RELAPSED AND REFRACTORY MULTIPLE MYELOMA, EVOLUTION AND COMPLICATIONS SINGLE CENTER EXPERIENCE

EHA Library, Hortensia Ionita, 134886

BENDAMUSTINE, LENALIDOMIDE AND DEXAMETHASONE (BLD) COMBINATION THERAPY IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE.

EHA Library, Lucia Ciuffreda, 134887

OUTCOME OF PATIENTS WITH NONSECRETORY AND SECRETORY MULTIPLE MYELOMA AFTER FIRST LINE TREATMENT CONSOLIDATED WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION. THE SINGLE CENTRE EXPERIENCE

EHA Library, Joanna Romejko-Jarosinska, 134888

PLASMABLASTIC LYMPHOMA (PBL) AND EXTRAMEDULLARY PLASMABLASTIC TRANSFORMATION OF PLASMA CELL MYELOMA (PCM) : DIAGNOSTIC MORHOLOGICAL, IMMUNOHISTOCHEMICAL AND CLINICAL CHARACTERISTICS

EHA Library, Chrissa Vadikolia, 134889

RETROSPECTIVE COMPARISON OF SAFETY AND EFFICACY OF BUCY AND HDM AS REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Song Jin, 134890

CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE (CTD) AS INITIAL THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.

EHA Library, Jule Vasquez, 134891